Literature DB >> 21111962

The role of radiation therapy in the management of cutaneous melanoma.

Nikhil G Rao1, Hsiang-Hsuan M Yu, Andrea Trotti, Vernon K Sondak.   

Abstract

Radiation therapy plays an integral role in the management of melanoma. Radiation therapy is infrequently needed for the treatment of the primary site, but there are occasions when it is appropriate. The role of adjuvant radiation therapy to resected nodal basins is becoming clearer from recent randomized data for patients at high risk. The role of radiotherapy combined with radiosensitizers, biologic or with hyperthermia, continues to evolve. Radiation therapy plays a vital role in the treatment of brain metastases and is useful for other systemic metastases. Emerging technology such as stereotactic radiation therapy may be useful in achieving durable palliation for selected patients.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21111962     DOI: 10.1016/j.soc.2010.09.005

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  5 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

2.  Use of Nanoparticles in Delivery of Nucleic Acids for Melanoma Treatment.

Authors:  Mohammad A Obeid; Alaa A A Aljabali; Meriem Rezigue; Haneen Amawi; Hanin Alyamani; Shatha N Abdeljaber; Valerie A Ferro
Journal:  Methods Mol Biol       Date:  2021

3.  A combination of high dose rate (10X FFF/2400 MU/min/10 MV X-rays) and total low dose (0.5 Gy) induces a higher rate of apoptosis in melanoma cells in vitro and superior preservation of normal melanocytes.

Authors:  Sreeja Sarojini; Andrew Pecora; Natasha Milinovikj; Joseph Barbiere; Saakshi Gupta; Zeenathual M Hussain; Mehmet Tuna; Jennifer Jiang; Laura Adrianzen; Jaewook Jun; Laurice Catello; Diana Sanchez; Neha Agarwal; Stephanie Jeong; Youngjin Jin; Yvonne Remache; Andre Goy; Alois Ndlovu; Anthony Ingenito; K Stephen Suh
Journal:  Melanoma Res       Date:  2015-10       Impact factor: 3.599

4.  Radiosensitization and downregulation of heterogeneous nuclear ribonucleoprotein K (hnRNP K) upon inhibition of mitogen/extracellular signal-regulated kinase (MEK) in malignant melanoma cells.

Authors:  Stefan Eder; Andreas Lamkowski; Markus Priller; Matthias Port; Konrad Steinestel
Journal:  Oncotarget       Date:  2015-07-10

5.  Proton Therapy Outcomes for Head and Neck Cutaneous Melanoma: Proton Collaborative Group Analysis.

Authors:  James E Han; Alicia Lozano; Shaakir Hasan; J Isabelle Choi; Arpit M Chhabra; Henry Tsai; Nasiruddin Mohammed; Samir Patel; Sanford Katz; John H Chang; Charles B Simone; Robert H Press
Journal:  Int J Part Ther       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.